New laboratory tool to find better treatments for resistant melanomas
7d agoen
From the article
Researchers have developed a new lab model to study BAP1-deficient melanomas, a rare type of melanoma that evade the immune system once they metastasize and are resistant to current immunotherapies.
Continue reading on healthcare-in-europe.comYou might also wanna read
Stocks in focus today: TCS, SBI, Tata Steel, NLC India, NALCO, JSW Energy, Aditya Infotech, M&M an more
thehindubusinessline.com·12m ago
Vercel Acquires Tekedia Capital Portfolio, Better Auth
Tekedia·14m ago
Collective agreement: Ritestart
Canadian HR Reporter·23m ago
Codenotary launches AgentMon 3 with adaptive runtime security policies for AI agents, now on AWS Marketplace
Codenotary has launched AgentMon 3, the latest version of its enterprise AI security platform, featuring adaptive runtime security policies
helpnetsecurity.com·26m ago
Continuity Infrastructure: The Emerging Enterprise AI Layer for Structural Gaps
This article introduces the concept of "continuity infrastructure" as an emerging architectural layer in enterprise AI systems. It argues th
hackernoon.com·27m ago
Flytxt Deploys AI Customer Engagement Platform for Digicel Trinidad & Tobago
Flytxt, an AI-powered enterprise marketplace optimization company, has deployed its AI customer engagement platform for Digicel Trinidad & T
thefastmode.com·28m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.